AstraZeneca outlook seen safer after 2030 amid pipeline newsflow
J.P. Morgan said AstraZeneca is due to report results from late-stage clinical trials next year that could improve investors’ confidence in its growth beyond 2030.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.